Cydan, LLC, an orphan drug accelerator that identifies and de-risks programs with therapeutic and commercial potential, today announced that the…
Super UserOctober 2, 2013
Human genome drugs: Where are the miracle cures from genomics? Did the genome map make us healthier?
Sequencing the human genome seemed like a discovery so important that it couldn’t be overhyped—we had, after all, transcribed the…
Super UserOctober 2, 2013
An early-stage investment fund founded by Revolution has raised $200 million in commitments, blowing past its $150 million goal. The…
Super UserOctober 2, 2013
At a time when many states are looking to their research universities as sources of innovation and entrepreneurship, it is…
Super UserSeptember 30, 2013
Emergent Biosolutions, the maker of the only FDA-licensed anthrax vaccine, is expanding its footprint in Montgomery County, with a little…
Super UserSeptember 30, 2013
These days, having a strategic investor or partner has become almost a matter of survival for healthcare startups. Corporate investing…
Super UserSeptember 30, 2013
Anyone can have a great business idea, and now students don’t have to be enrolled in the business school to…
Super UserSeptember 30, 2013
Earlier this year Sun Yat-sen University, a well-regarded institution in Guangzhou in the Guangdong province of China, announced that the…
Super UserSeptember 30, 2013
Bureaucracy is one of the dirty words in business. Nobody wants to publicly admit their company is bogged down with…
Super UserSeptember 30, 2013
Gliknik Enters Into Licensing Agreement With Pfizer for Drug Candidate Targeting Autoimmune Diseases
GL-2045 is Gliknik’s Lead Recombinant Stradomer™ Designed to Improve on Pooled Human Intravenous Immunoglobulin Gliknik Inc., a privately held biopharmaceutical…
Super UserSeptember 30, 2013